Source:http://linkedlifedata.com/resource/pubmed/id/20133101
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2010-2-17
|
pubmed:abstractText |
Clinically used anticoagulant warfarin is usually available as a racemic mixture of S- and R-warfarin that are both metabolized mainly by cytochrome P450 isoenzymes. Determination of warfarin enantiomers and their enantiomeric 7-hydroxywarfarin (7-OH-warfarin) metabolites in the human plasma sample allows probing of cytochrome P450 isoenzyme activities and detection of ingestion of warfarin-containing products for the investigation of unexplained bleeding. The present study aims to develop a sensitive and specific liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for simultaneous detection of S-warfarin, R-warfarin, S-7-OH-warfarin and R-7-OH-warfarin in human plasma. Plasma samples were extracted with mixed-mode cation-exchange (MCX) cartridge with recoveries of greater than 87.0% for all four analytes. The selectivity of 7-OH-warfarin from other monohydroxylated warfarin metabolites such as 4'-, 6-, 8- and 10-hydroxywarfarins using a Chirobiotic V chiral column and multiple reaction monitoring (MRM) was addressed. The developed LC-MS/MS method is simple, specific and has been fully validated with satisfactory accuracy and adequate reproducibility with limit of quantification (LOQ) of 5 ng/ml for all four analytes. The method was successfully applied to analyze the steady state plasma concentrations of the four analytes in 30 patients.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1873-264X
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright (c) 2010 Elsevier B.V. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:day |
5
|
pubmed:volume |
52
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
305-10
|
pubmed:meshHeading |
pubmed-meshheading:20133101-Anticoagulants,
pubmed-meshheading:20133101-Calibration,
pubmed-meshheading:20133101-Chromatography, Liquid,
pubmed-meshheading:20133101-Drug Stability,
pubmed-meshheading:20133101-Freezing,
pubmed-meshheading:20133101-Humans,
pubmed-meshheading:20133101-Molecular Structure,
pubmed-meshheading:20133101-Reference Standards,
pubmed-meshheading:20133101-Reproducibility of Results,
pubmed-meshheading:20133101-Sensitivity and Specificity,
pubmed-meshheading:20133101-Solid Phase Extraction,
pubmed-meshheading:20133101-Stereoisomerism,
pubmed-meshheading:20133101-Tandem Mass Spectrometry,
pubmed-meshheading:20133101-Temperature,
pubmed-meshheading:20133101-Time Factors,
pubmed-meshheading:20133101-Warfarin
|
pubmed:year |
2010
|
pubmed:articleTitle |
Simultaneous measurement of S-warfarin, R-warfarin, S-7-hydroxywarfarin and R-7-hydroxywarfarin in human plasma by liquid chromatography-tandem mass spectrometry.
|
pubmed:affiliation |
School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong, SAR. joanzuo@cuhk.edu.hk
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|